Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

References

Page 1

	Year	Citations
Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype Franco Aversa, Antonio Tabilio, Andrea Velardi, New England Journal of Medicine	1998	1.2K
Logistic Regression, Survival Analysis, and the Kaplan-Meier Curve Bradley Efron Journal of the American Statistical Association Hazard RatesPrognosisLogistic RegressionParametric RegressionBiostatistics	1988	970
Analysing Survival Data From Clinical Trials and Observational Studies Technometrics Observational StudiesPrognostic AssessmentPrognostic EvaluationPrognosisClinical Trials	1996	664
Stable Mixed Hematopoietic Chimerism in DLA-Identical Littermate Dogs Given Sublethal Total Body Irradiation Before and Pharmacological Immunosuppression After Marrow Transplantation Rainer Storb, Cong Yu, John L. Wagner, Blood	1997	614
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Richard Szydlo, John M. Goldman, John P. Klein, Journal of Clinical Oncology	1997	474
Analysing Survival Data from Clinical Trials and Observational Studies Eric R. Ziegel, E. Marubini, M. Valsecchi Technometrics Survival DataPrognosisClinical TrialsOutcomes ResearchBiostatistics	1996	265
Granulocyte–colony-stimulating factor (G-CSF)–primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF–mobilized peripheral blood stem cells James Morton, Cheryl Hutchins, Simon Durrant Blood	2001	177
Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia RC Ash, JT Casper, T McAuliffe, Blood	1994	126
Superior survival associated with transplantation of matched unrelated versus one-antigen–mismatched unrelated or highly human leukocyte antigen– disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts William R. Drobyski, John P. Klein, Neal Flomenberg, Blood	2002	98
In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Chang Ying Jun, Zhao Yu PubMed	2004	91

Page 1